|
Πέμπτη 17 Δεκεμβρίου 2020
High-Dose Omalizumab versus Ligelizumab for the Treatment of Chronic Spontaneous Urticaria: Do Not We Need a Head-To-Head Comparison?
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: Available online 18 July 2017 Source: Journal of Voice Author(s): E. Lucchini, A. Ricci Maccarini, E. Bissoni, M. Borrag...
-
Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00306932607174,00302841026182, alsfakia@gmail.com http://ift.tt/...
-
Volume 2, Issue 1 , December 2017, Page 77-80 . http://ift.tt/2p6xgHQ http://ift.tt/2p76sa9
-
Background: Cyclicity is the essential feature of Bipolar disorder, but the effect of different cycle patterns on the clinical features is p...
-
http://ift.tt/2rzpBWF Alexandros Sfakianakis Anapafseos 5 . Agios Nikolaos Crete.Greece.72100 2841026182 6948891480 alsfakia@gma...
-
A Phase 2 Study of Actinium-225 (225Ac)-Lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML) - Interim Analysis of 1.5 µ...
-
Abstract Objectives To investigate the association of residential mobility with flourishing among school-age children. Methods Data from...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου